{
    "Trade/Device Name(s)": [
        "BD MAX\u2122 CT/GC/TV",
        "BD MAX\u2122"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K151589",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081824",
        "K081825",
        "K130268"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MKZ",
        "LSL",
        "OUY"
    ],
    "Summary Letter Date": "August 19, 2016",
    "Summary Letter Received Date": "August 22, 2016",
    "Submission Date": "September 1, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3120",
        "21 CFR 866.3390",
        "21 CFR 866.3860"
    ],
    "Regulation Name(s)": [
        "Chlamydia serological reagents",
        "Neisseria spp. direct serological test reagents",
        "Trichomonas vaginalis Nucleic Acid Amplification Test System"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis",
        "Neisseria gonorrhoeae",
        "Trichomonas vaginalis"
    ],
    "Specimen Type(s)": [
        "Male urine",
        "Female urine",
        "Clinician-collected female endocervical swab",
        "Patient-collected vaginal swab"
    ],
    "Specimen Container(s)": [
        "BD MAX UVE Sample Buffer Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated DNA extraction",
        "Real-time PCR"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Qualitative detection",
        "Real-time PCR"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Instrument",
        "Cartridge",
        "Reagent",
        "Software",
        "Accessory",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for BD MAX CT/GC/TV assay on BD MAX System using automated DNA extraction and real-time PCR to detect CT, GC, and TV in urogenital specimens",
    "Indications for Use Summary": "Qualitative detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis DNA in male urine, female urine, clinician-collected female endocervical swab, and patient-collected vaginal swab specimens to aid in diagnosing urogenital disease and trichomoniasis in symptomatic and asymptomatic individuals",
    "fda_folder": "Immunology"
}